AASLD |
American Association for the Study of Liver Diseases |
ALT |
alanine transaminase |
AST |
aspartate transaminase |
BMI |
body mass index |
CAP |
controlled attenuation parameter |
EASD |
European Association for the Study of Diabetes |
EASL |
European Association for the Study of the Liver |
EASO |
European Association for the Study of Obesity |
ENPP1 |
ectonucleotide pyrophosphatase phosphodiesterase 1 |
ESPGHAN |
European Society of Pediatric Gastroenterology, Hepatology and Nutrition |
FIB-4 |
fibrosis-4 |
GCKR |
glucokinase regulator |
GGT |
gamma-glutamyltransferase |
GWAS |
genome-wide association studies |
HSL |
hormone-sensitive lipase |
IR |
insulin resistance |
MAFLD |
metabolic associated fatty liver diseases |
MRE |
magnetic resonance elastography |
MRI-PDFF |
magnetic resonance (MR) imaging–proton density fat fraction |
MRS-PDFF |
MR spectroscopy–proton density fat fraction |
NAFL |
nonalcoholic fatty liver |
NAFLD |
nonalcoholic fatty liver disease |
NASPGHAN |
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition |
NASH |
nonalcoholic steatohepatitis |
PNFI |
Pediatric NAFLD Fibrosis Index |
PNFS |
Pediatric NAFLD Fibrosis Score |
PNPLA3 |
patatin-like phospholipase domain-containing protein 3 |
PPAR |
peroxisome proliferator-activated receptor |
RCT |
randomized clinical trial |
SIRT1 |
sirtuin-1 |
TE |
transient elastography |
TM6SF2 |
transmembrane 6 superfamily member 2 |
USS |
ultrasound scan |
VLDL |
very low density lipoprotein |